World Journal of Gastrointestinal Pharmacology and Therapeutics

BPG is committed to discovery and dissemination of knowledge

Cited by in CrossRef

For:	Ramos H, Linares P, Badia E, Martín I, Gómez J, Almohalla C, Jorquera F, Calvo S, García I, Conde P, Álvarez B, Karpman G, Lorenzo S, Gozalo V, Vásquez M, Joao D, de Benito M, Ruiz L, Jiménez F, Sáez-Royuela F, Asociación Castellano y Leonesa de Hepatología (ACyLHE). Interferon-free treatments in patients with hepatitis C genotype 1-4 infections in a real-world setting. World J Gastrointest Pharmacol Ther 2017; 8(2): 137-146 [PMID: 28533924 DOI: 10.4292/wjgpt.v8.i2.137]
URL:	https://www.wjgnet.com/2150-5349/full/v8/i2/137.htm

For:

Ramos H, Linares P, Badia E, Martín I, Gómez J, Almohalla C, Jorquera F, Calvo S, García I, Conde P, Álvarez B, Karpman G, Lorenzo S, Gozalo V, Vásquez M, Joao D, de Benito M, Ruiz L, Jiménez F, Sáez-Royuela F, Asociación Castellano y Leonesa de Hepatología (ACyLHE). Interferon-free treatments in patients with hepatitis C genotype 1-4 infections in a real-world setting. World J Gastrointest Pharmacol Ther 2017; 8(2): 137-146 [PMID: 28533924 DOI: 10.4292/wjgpt.v8.i2.137]

URL:

https://www.wjgnet.com/2150-5349/full/v8/i2/137.htm

(432) (408) (0) (0) (0) (7570) (17)

Number	Citing Articles
1	Kellie Young, Benny Liu, Taft Bhuket, Robert G. Gish, Robert J. Wong. Improved liver transplant waitlist mortality and lower risk of disease progression among chronic hepatitis C patients awaiting liver transplantation after the introduction of direct‐acting antiviral therapies in the United States. Journal of Viral Hepatitis 2019; 26(3) doi: 10.1111/jvh.13039
2	Jose Luis Calleja, Jaime Espin, Ankita Kaushik, Manuel Hernandez-Guerra, Rob Blissett, Alon Yehoshua, Adam Igloi-Nagy. The Efficiency of Increased HCV Testing and Treatment Strategies in Spain to Achieve Elimination Goals. PharmacoEconomics - Open 2024; 8(2) doi: 10.1007/s41669-023-00458-3
3	Rion Masaoka, Yoshinori Gyotoku, Ryosaku Shirahashi, Toshikuni Suda, Masaya Tamano. Combining the age-male-albumin-bilirubin-platelets score and shear wave elastography stratifies carcinogenic risk in hepatitis C patients after viral clearance. World Journal of Clinical Cases 2023; 11(22) doi: 10.12998/wjcc.v11.i22.5198 Abstract(0) \| Core Tip(0) \| Full Article(HTML)(0) \| Times Cited (0) \| Total Visits (0) \| Open
4	Maia Butsashvili, Lia Gvinjilia, George Kamkamidze, David Metreveli, Shorena Dvali, Tamar Rukhadze, Amiran Gamkrelidze, Muazzam Nasrullah, Shaun Shadaker, Juliette Morgan, Francisco Averhoff. High sustained viral response among HCV genotype 3 patients with advanced liver fibrosis: real-world data of HCV elimination program in Georgia. BMC Research Notes 2020; 13(1) doi: 10.1186/s13104-020-05173-4
5	Maoping Li, Wan Hu, Zhongshang Dai, Jie Li, Jing Ma, Yi Li. Innovative management of hepatitis C: implementation and outcomes of the ‘SMART’ model in a general hospital. Journal of Global Health 2026; 16 doi: 10.7189/jogh.16.04241
6	Hugo Perazzo, Marcelino Jose Jorge, Julio Castro Silva, Alexandre Monken Avellar, Patrícia Santos Silva, Carmen Romero, Valdilea Gonçalves Veloso, Ruben Mujica-Mota, Rob Anderson, Chris Hyde, Rodolfo Castro. Micro-costing analysis of guideline-based treatment by direct-acting agents: the real-life case of hepatitis C management in Brazil. BMC Gastroenterology 2017; 17(1) doi: 10.1186/s12876-017-0676-8
7	Romeo-Gabriel Mihăilă. Liver stiffness in chronic hepatitis C virus infection. Romanian Journal of Internal Medicine 2019; 57(2) doi: 10.2478/rjim-2018-0034
8	Reza Taherkhani, Fatemeh Farshadpour. Global elimination of hepatitis C virus infection: Progresses and the remaining challenges. World Journal of Hepatology 2017; 9(33): 1239-1252 doi: 10.4254/wjh.v9.i33.1239 Abstract(1511) \| Core Tip(1523) \| Full Article(HTML)(7128) \| Full Article (PDF)-2399K(1137) \| Full Article (Word)-447K(393) \| Audio-1604K(55) \| Peer-Review Report-160K(360) \| Answering Reviewers-137K(410) \| Times Cited (55) \| Total Visits (10139) \| Open
9	Rafael Esteban, Raquel Domínguez-Hernández, Victoria Martín-Escudero, Miguel Ángel Casado, Matteo Ruggeri. Clinical and economic value of sofosbuvir-based regimens in the treatment of chronic hepatitis C in Spain. PLOS ONE 2022; 17(12) doi: 10.1371/journal.pone.0278544
10	Rion Masaoka, Yoshinori Gyotoku, Ryosaku Shirahashi, Toshikuni Suda, Masaya Tamano. Combining the age-male-albumin-bilirubin-platelets score and shear wave elastography stratifies carcinogenic risk in hepatitis C patients after viral clearance. World Journal of Clinical Cases 2023; 11(22): 5204-5214 doi: 10.12998/wjcc.v11.i22.5204 Abstract(1112) \| Core Tip(863) \| Full Article(HTML)(2522) \| Full Article (PDF)-741K(303) \| Full Article with Cover (PDF)-1083K(298) \| Full Article (Word)-299K(123) \| Full Article (XML)-127K(172) \| Audio-1557K(12) \| Peer-Review Report-293K(181) \| Answering Reviewers-162K(186) \| Times Cited (3) \| Total Visits (4726) \| Open
11	Juan Turnes, Raquel Domínguez-Hernández, Miguel Ángel Casado. Cost-effectiveness analysis of two treatment strategies for chronic hepatitis C before and after access to direct-acting antivirals in Spain. Gastroenterología y Hepatología (English Edition) 2017; 40(7) doi: 10.1016/j.gastre.2017.07.008
12	Ulrich Spengler. Direct antiviral agents (DAAs) - A new age in the treatment of hepatitis C virus infection. Pharmacology & Therapeutics 2018; 183 doi: 10.1016/j.pharmthera.2017.10.009
13	Yoshinori Gyotoku, Ryosaku Shirahashi, Toshikuni Suda, Masaya Tamano. Role of liver stiffness measurements in patients who develop hepatocellular carcinoma after clearance of the hepatitis C virus. Journal of Medical Ultrasonics 2022; 49(2) doi: 10.1007/s10396-021-01188-x
14	Juan Turnes, Raquel Domínguez-Hernández, Miguel Ángel Casado. Análisis coste-efectividad de dos estrategias de tratamiento para la hepatitis C crónica: antes y después del acceso a los agentes antivirales de acción directa en España. Gastroenterología y Hepatología 2017; 40(7) doi: 10.1016/j.gastrohep.2017.05.004
15	Bryan Tolentino, Ritu R Singh, Suresh Misra, Douglas T Dieterich, Dost Sarpel. An Update On the Management of Hepatitis C Virus and Human Immunodeficiency Virus co-infection. Future Virology 2019; 14(3) doi: 10.2217/fvl-2018-0116
16	I. A. Narkevich, E. A. Tsitlionok. Development of approaches to the evaluation of pharmacotherapy effectiveness for chronic hepatitis C. FARMAKOEKONOMIKA. Modern Pharmacoeconomics and Pharmacoepidemiology 2023; 16(4) doi: 10.17749/2070-4909/farmakoekonomika.2023.193
17	Kellie Young, Benny Liu, Taft Bhuket, Robert J. Wong. Lower Likelihood of Post-transplant Graft Failure, Death, and Retransplantation in the Era of Direct-Acting Antivirals. Journal of Clinical and Experimental Hepatology 2020; 10(6) doi: 10.1016/j.jceh.2020.02.003